Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CRISPR01:59

CRISPR

49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K
CRISPR and crRNAs02:53

CRISPR and crRNAs

16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Homologous Recombination02:31

Homologous Recombination

50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

USP Gene Network Modulation and Osmoprotection Define Salt Resilience in Chenopodium quinoa Genotypes.

Scientific reports·2026
Same author

Ondansetron derivatives as potential PTP1B inhibitors for treating type 2 diabetes mellitus: <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> analysis.

Frontiers in pharmacology·2026
Same author

Integrated morpho-physiological, metabolomic and transcriptomic profiling uncovers ethylene-mediated metabolic regulation shaping drought resilience in wheat.

BMC plant biology·2026
Same author

Ethylene signaling and metabolite reprogramming in salt tolerance of Triticum aestivum.

Scientific reports·2026
Same author

Corrigendum to "Repurposing of FDA-approved drugs to identify potential NS2B/NS3 protease inhibitors against dengue virus: In silico and in vitro evaluation" [Acta Tropica volume 274 (2026) 107987].

Acta tropica·2026
Same author

Molecular docking of the DREB(A-6) group and enhanced thermotolerance in potato by overexpressing the DREB(A-6) gene.

Journal of plant research·2026

相关实验视频

Updated: Jun 13, 2025

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

476

在表观遗传学CRISPR-Cas系统的进步.

Mahnoor Ilyas1, Qasim Shah2, Alvina Gul3

  • 1Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan; Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.

Progress in molecular biology and translational science
|September 12, 2024
PubMed
概括

克里斯普尔-卡斯9系统使精确的表观遗传修饰成为可能,为了解和治疗与DNA甲基化和基因组变化相关的疾病提供了新的途径. 这项技术对基因编辑的未来临床应用具有前景.

关键词:
克里斯普尔-Cas9是什么意思克里斯普拉是一个.克里斯普里是指克里斯普里.表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.基质子的修改 基质子的修改

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.5K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.4K

相关实验视频

Last Updated: Jun 13, 2025

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

476
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.5K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.4K

科学领域:

  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.
  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

  • 表观遗传修饰,包括DNA甲基化和基因质突变,在人类疾病的发病过程中至关重要.
  • 虽然DNA和染色质的修饰已被理解,但RNA核酸的改变正在引起人们的注意.
  • 基于CRISPR的表观遗传编辑工具可以精确控制这些修改.

研究的目的:

  • 探索CRISPR-Cas9系统在表观遗传修饰中的作用.
  • 突出CRISPR-Cas9在人类疾病治疗中的潜在应用.
  • 讨论基于CRISPR的临床应用表观遗传编辑方面的进展.

主要方法:

  • 使用催化无活性的Cas9 (dCas9) 与表观遗传修饰剂 (基因组编码编辑器,DNA甲基转移酶) 相结合.
  • 使用CRISPR干扰 (CRISPRi) 和CRISPR激活 (CRISPRa) 来进行针对性的表观遗传编辑.
  • 专注于选择性DNA修饰以维持表观遗传记忆.

主要成果:

  • 克里斯普尔-Cas9系统在编辑真核细胞表观基因组方面表现出高效.
  • 基于CRISPR的工具允许选择性DNA修改,从而保留表观遗传记忆.
  • 技术的进步有助于在临床研究中操纵CRISPR-Cas9.

结论:

  • 克里斯普尔-Cas9系统为表观遗传修饰提供了一个强大的平台.
  • 精确的表观遗传编辑对于理解和潜在治疗癌症等疾病至关重要.
  • 优化交付平台将提高CRISPR-Cas9在基因编辑疗法中的临床实用性.